Alogliptin Impurity 44 | CAS 67013-55-2 - Request Quote
Alogliptin Impurity 44
| SZ CAT No: | SZ-A053067 |
| CAS No | 67013-55-2 |
| Mol.F. | C8H5Br2N |
| Mol.Wt. | 274.9 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Alogliptin Impurity 44 is chemically 4-(Dibromomethyl)benzonitrile. Alogliptin Impurity 44 is supplied with detailed characterization data compliant with regulatory guideline. Alogliptin Impurity 44 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Alogliptin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 67013-55-2
Purchase 67013-55-2
Order 67013-55-2
Enquire 67013-55-2
price of 67013-55-2
67013-55-2 Supplier
67013-55-2 Manufacturer
67013-55-2 Exporter
buy high quality Alogliptin Impurity 44
Purchase Alogliptin Impurity 44
Alogliptin Impurity 44 suppliers
Alogliptin Impurity 44 manufacturers
Alogliptin Impurity 44 price
Order Alogliptin Impurity 44
Enquire Alogliptin Impurity 44
Alogliptin Impurity 44 cost
Alogliptin Impurity 44 Supplier
Alogliptin Impurity 44 Distributor
Alogliptin Impurity 44 for Method Validation
Alogliptin Reference Standard
Alogliptin Impurity 44 for ANDA Filing
Alogliptin Impurity 44 for Forced Degradation Studies
Alogliptin Impurity 44 Identification Standards
Alogliptin Impurity 44 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.